Task: Answer the multiple choice question.
Question: Which drug exhibits a -56.297% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1ccc(-c2cc(C(F)(F)F)n3nc(C(=O)N4CCCC4)cc3n2)cc1
b. CSc1nc(C)cc(Oc2ccc(=O)[nH]n2)n1
c. CCCc1ccc(C(=O)N2CCN(c3ccccc3OCC)CC2)cc1
Answer: c. CCCc1ccc(C(=O)N2CCN(c3ccccc3OCC)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1ccc(C(=O)N2CCN(c3ccccc3OCC)CC2)cc1
CCCc1ccc(C(=O)N2CCN(c3ccccc3OCC)CC2)cc1
[4-(2-ethoxyphenyl)piperazin-1-yl]-(4-propylphenyl)methanone